Welcome to our dedicated page for BlackRock ESG Capital Allocation Term Trust SEC filings (Ticker: ECAT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for BlackRock ESG Capital Allocation Term Trust (NYSE: ECAT) brings together the fund’s regulatory disclosures as a non-diversified, closed-end management investment company. As a registered investment company, ECAT files documents with the U.S. Securities and Exchange Commission that describe its structure, investment objectives, governance, and material corporate actions.
Regulatory materials referenced in public announcements include tender offer statements on Schedule TO, proxy statements for annual meetings, and related exhibits. Tender offer documents outline the terms under which ECAT has offered to repurchase a portion of its outstanding common shares, including the percentage of shares subject to the offer and the method for determining the purchase price as a percentage of net asset value on a specified date.
Proxy statements and associated filings provide details on proposals submitted to shareholders, such as the election of trustees and a shareholder proposal to terminate BlackRock Advisors, LLC as investment adviser. These filings also form the basis for recommendations issued by proxy advisory firms Institutional Shareholder Services, Glass Lewis, and Egan-Jones, which are discussed in Business Wire releases.
Litigation involving ECAT’s voting bylaws, brought by Saba Capital Management, L.P., is also connected to the fund’s regulatory framework under the Investment Company Act. Court rulings described in public news highlight questions about how ECAT’s voting standards interact with statutory requirements for shareholder elections and board composition.
On Stock Titan, ECAT’s SEC filings are supplemented with AI-powered summaries that explain the key points of lengthy documents in plain language. Real-time updates from the SEC’s EDGAR system allow users to see new filings as they appear, while AI-generated highlights help identify important items in tender offer statements, proxy materials, and other disclosures. This structure enables investors to review ECAT’s regulatory history, advisory arrangements, and governance-related filings more efficiently.
Saba Capital Management, L.P., a more-than-ten-percent owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported an open-market sale of common stock. On April 27, 2026, it sold 44,101 shares at $14.79 per share. After this transaction, Saba Capital Management, L.P. reported 21,335,844 shares of ECAT common stock held indirectly.
Saba Capital Management and related reporting persons have updated their Schedule 13D/A on BlackRock ESG Capital Allocation Term Trust. They report beneficial ownership of 21,379,945 common shares, representing 21.49% of the fund’s common shares based on 99,468,307 shares outstanding as of 12/31/25.
According to the filing, approximately $317,821,841 was paid in total to acquire these shares, funded by investor subscriptions, capital appreciation and ordinary-course margin borrowings. All trades since the prior amendment on 3/18/26 through 4/24/26 were executed in the open market, with details listed in Schedule A.
Saba Capital Management, L.P., a more than ten percent owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported an open-market sale of 115,170 shares of common stock on April 24, 2026 at $14.66 per share. After this indirect transaction, Saba Capital’s reported holdings in ECAT common stock totaled 21,379,945 shares, indicating it remains a very large shareholder.
Saba Capital Management, L.P., a ten percent owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported two open-market sales of Common Stock. It sold 10,350 shares at $14.61 per share on April 22, 2026 and 8,935 shares at $14.64 per share on April 21, 2026, totaling 19,285 shares. After these transactions, Saba Capital indirectly owned 21,495,115 ECAT shares, indicating the sales were small relative to its overall position.
Saba Capital Management, L.P., a more than ten percent owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported an open-market sale of 13,782 shares of common stock at $14.62 per share. After this transaction, it still indirectly holds 21,514,400 shares, so the sale represents a small portion of its position.
Saba Capital Management, L.P., a ten percent owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported two open-market sales of common stock. On April 17, 2026, it sold 87,990 shares at $14.69 per share, and on April 16, 2026, it sold 39,758 shares at $14.51 per share. After these indirect transactions, Saba Capital remained with 21,528,182 shares of ECAT, indicating it still holds a large position despite trimming its stake.
Saba Capital Management, L.P., a ten percent owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported an open-market sale of 62,841 shares of common stock at $14.68 per share. After this transaction, Saba’s indirect holdings stand at 21,655,930 shares of ECAT common stock.
Saba Capital Management, L.P., a more than ten percent owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported open-market purchases of the trust’s common shares. On April 1 and 2, it bought a combined 303,392 shares at $13.87 per share, bringing its direct holdings to 21,718,771 shares.
Saba Capital Management, L.P., a more than ten percent owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported open-market sales of the trust’s common stock. On March 31, 2026, it sold 224,477 shares at an average price of $13.73 per share. On March 30, 2026, it sold 37,868 shares at an average price of $13.52 per share. Following these transactions, Saba Capital indirectly held 22,022,163 ECAT shares, indicating these sales reduced but did not eliminate its sizable position.
Saba Capital Management, L.P., a ten percent owner of BlackRock ESG Capital Allocation Term Trust, reported two open-market sales of the trust’s common stock. On March 27, 2026, it sold 88,419 shares at $13.59 per share, and on March 26, 2026, it sold 37,606 shares at $13.87 per share. After these indirect sales, Saba Capital reported owning 22,284,508 common shares.